Topspin Medical
Develops an innovative and unique technology for high-resolution MRI using an IntraVascular MRI (IVMRI) catheter for the coronary arteries, without the need for an expensive and bulky external MRI…
About Topspin Medical
Topspin Medical, established in 1999, was a medical device company that operated from Lod, Israel, focusing on the cardiovascular diagnostics market. The company was the result of a collaboration between its founders, Erez Golan and Eyal Kolka. Erez Golan, a physicist who previously led a cardiovascular imaging group at Medinol, was the inventor behind the company's core technology and served as its CEO. Eyal Kolka, who had a background in investment banking, took on the roles of CFO and Senior VP of Business Development.
The firm's primary business was the development and commercialization of a novel medical imaging technology. Its flagship product, the Catharman system, was an intravascular MRI (IVMRI) catheter. This device was engineered to provide high-resolution imaging of coronary artery walls directly during cardiac catheterization, a significant departure from conventional MRI which requires large, expensive external magnets. The main benefit was its ability to characterize the lipid composition of atherosclerotic plaques, helping to identify vulnerable plaques prone to rupture, a leading cause of heart attacks. The target clients were interventional cardiologists and hospitals performing cardiac catheterization procedures.
Topspin Medical's journey included several key financial and operational milestones. In 2002, it secured $16.5 million in a Series B financing round led by Pitango Venture Capital and Giza Venture Capital, with Johnson & Johnson also participating. The company went public on the Tel Aviv Stock Exchange (TASE: TOPMD) in 2005. A significant post-IPO financing of $11 million was raised in 2006 to fund the commercial launch in Europe and the US. A notable commercial step was a distribution agreement with Johnson & Johnson announced in 2007. The first commercial installation of the Catharman system occurred in a Belgian hospital in early 2008. Despite these achievements, including obtaining a CE Mark and conducting clinical trials, the company is now reported to be defunct.
Source: Dealroom company dataNews
Open roles
Topspin Medical in its local ecosystem
The Topspin Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Giza Venture Capital
Pitango Venture Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Topspin Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Topspin Medical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
